Compare Corsair Gaming Inc (CRSR) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Corsair Gaming Inc vs BIO-TECHNE Corp — how do they compare? Corsair Gaming Inc trades at $12.97 (market cap $1.48B), while BIO-TECHNE Corp trades at $72.13 (market cap $11.24B). The key difference: BIO-TECHNE Corp is far larger — about 7.6× Corsair Gaming Inc's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while Corsair Gaming Inc pays none. Which is the better fit depends on your goals.
| CRSR | TECH | |
|---|---|---|
Market Cap | $1.48B | $11.24B |
Sector | Technology | Health |
52-Week High | $14.35 | $72.29 |
52-Week Low | $4.58 | $43.31 |
Enterprise Value | $1.48B | $11.32B |
Dividend Yield | — | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Corsair Gaming (CRSR) surged 35.25% to $14.35, driven by strong Q2 2026 earnings that beat expectations and raised full-year guidance. The stock is in a bullish technical trend, trading near resistance at $15.00, with RSI indicating overbought conditions. Revenue was $1.47 billion in 2025, with net income improving to a projected $37 million profit in 2026, though margins remain slim. Recent news highlights growth in AI and sim racing segments, including the Trak Racer acquisition.
Outlook is positive due to earnings momentum and strategic expansions, but risks include high valuation (P/E 46.37) and competitive pressures. Analysts are mixed with a $12.40 consensus target, suggesting caution after the rally. Key opportunities lie in margin improvement and AI product adoption, while volatility and execution challenges pose near-term risks.
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Corsair Gaming Inc
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue generating segment
Read more on CRSR →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
